<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>metabolic fingerprinting is_biomarker_for colorectal cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>metabolic fingerprinting</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>colorectal cancer</strong>
</div>
<div class="entity-id">UNKNOWN:metabolic fingerprinting &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: DB Referenced (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 3.85<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (DB Referenced, 1 paper)<br>Score from 12 citations: <strong>3.85</strong><br><span style="color:#888">3&times; extends (+1.80) &middot; 5&times; supports (+2.50) &middot; 3&times; contradicts (-0.75) &middot; 1&times; applies (+0.30)</span><br>Neighbourhood: 6.47</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="DB Referenced"></span><span>DB Referenced</span><a href="https://doi.org/10.1586/17474124.2014.945912">10.1586/17474124.2014.945912</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 12 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>5</span><span class="cite-subtotal">&middot; +2.50</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">propofol — decreases → plasma metabolite levels</span><span class="cite-claim-weight">+0.50</span><a href="../claim/29decb4e7e4a37a2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">general anesthesia — decreases → interpersonal metabolic variability</span><span class="cite-claim-weight">+0.50</span><a href="../claim/9dab02fad13208e0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fatty acid metabolites — distinguishes → Hmga1 transgenic mice with polyposis</span><span class="cite-claim-weight">+0.50</span><a href="../claim/a87c99a18d869598.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">arginine-enriched tetra-peptide fragments — increases → Hmga1 transgenic mice with polyposis</span><span class="cite-claim-weight">+0.50</span><a href="../claim/99363b5c93ff71bb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fecal metabolome — distinguishes → colorectal cancer precursor lesions (polyposis)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/18e4a43c8b99b01f.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:60px"></span><span>3</span><span class="cite-subtotal">&middot; -0.75</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">etomidate — decreases → plasma metabolite levels</span><span class="cite-claim-weight">-0.25</span><a href="../claim/b8b785fe3e97032d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">etomidate — distinguishes → propofol anesthesia</span><span class="cite-claim-weight">-0.25</span><a href="../claim/ce248bc3067606e3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Ficoll separation — causes → spurious NMR signals in plasma</span><span class="cite-claim-weight">-0.25</span><a href="../claim/17ce73c7b7e3a544.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:60px"></span><span>3</span><span class="cite-subtotal">&middot; +1.80</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">hypoxanthine — is_biomarker_for → colorectal cancer precursor lesions (polyposis)</span><span class="cite-claim-weight">+0.60</span><a href="../claim/7f9ac3cacb789536.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">xanthine — is_biomarker_for → colorectal cancer precursor lesions (polyposis)</span><span class="cite-claim-weight">+0.60</span><a href="../claim/9161e9f137fb1277.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">taurine — is_biomarker_for → colorectal cancer precursor lesions (polyposis)</span><span class="cite-claim-weight">+0.60</span><a href="../claim/108b69e73c3a3189.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:20px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolomics — predicts → individual metabolic response to anesthesia</span><span class="cite-claim-weight">+0.30</span><a href="../claim/cc87ae320f61246d.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>f0737c1eb31546ec</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:metabolic fingerprinting">UNKNOWN:metabolic fingerprinting</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
